An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation DOI Creative Commons
Ketty Sinigaglia, Anna Cherian,

Qiupei Du

и другие.

Cell Reports, Год журнала: 2024, Номер 43(8), С. 114618 - 114618

Опубликована: Авг. 1, 2024

Adar null mutant mouse embryos die with aberrant double-stranded RNA (dsRNA)-driven interferon induction, and Mavs double mutants, in which induction is prevented, soon after birth. Protein kinase R (Pkr) aberrantly activated pup intestines before death, intestinal crypt cells die, villi are lost. Eifak2 triple mice rescue all defects have long-term survival. Adenosine deaminase acting on 1 (ADAR1) PKR co-immunoprecipitate from cells, suggesting inhibition by direct interaction. AlphaFold studies an inhibitory dsRNA binding domain (dsRBD)-kinase interaction ADAR1 dsRBD3-PKR provide a testable model of the inhibition. Wild-type or editing-inactive human expressed A549 inhibits activation endogenous PKR. required for, but not sufficient Mutating contact prevents co-immunoprecipitation, activity, co-localization cells.

Язык: Английский

ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis DOI Creative Commons
Rajendra Karki, Balamurugan Sundaram, Bhesh Raj Sharma

и другие.

Cell Reports, Год журнала: 2021, Номер 37(3), С. 109858 - 109858

Опубликована: Окт. 1, 2021

Cell death provides host defense and maintains homeostasis. Zα-containing molecules are essential for these processes. Z-DNA binding protein 1 (ZBP1) activates inflammatory cell death, PANoptosis, whereas adenosine deaminase acting on RNA (ADAR1) serves as an editor to maintain Here, we identify characterize ADAR1's interaction with ZBP1, defining its role in regulation tumorigenesis. Combining interferons (IFNs) nuclear export inhibitors (NEIs) ZBP1-dependent PANoptosis. ADAR1 suppresses this PANoptosis by interacting the Zα2 domain of ZBP1 limit RIPK3 interactions. Adar1

Язык: Английский

Процитировано

277

ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation DOI
Richard de Reuver, Simon Verdonck, Evelien Dierick

и другие.

Nature, Год журнала: 2022, Номер 607(7920), С. 784 - 789

Опубликована: Июль 20, 2022

Язык: Английский

Процитировано

166

ADAR1 averts fatal type I interferon induction by ZBP1 DOI Creative Commons
Huipeng Jiao, Laurens Wachsmuth, Simone Wolf

и другие.

Nature, Год журнала: 2022, Номер 607(7920), С. 776 - 783

Опубликована: Июль 20, 2022

Mutations of the ADAR1 gene encoding an RNA deaminase cause severe diseases associated with chronic activation type I interferon (IFN) responses, including Aicardi-Goutières syndrome and bilateral striatal necrosis1-3. The IFN-inducible p150 isoform contains a Zα domain that recognizes alternative left-handed double-helix structure, termed Z-RNA4,5. Hemizygous mutations in IFN-mediated pathologies humans2,3 mice6-8; however, it remains unclear how interaction Z-RNA prevents IFN activation. Here we show Z-DNA-binding protein 1 (ZBP1), only other mammals known to harbour domains9, promotes fatal pathology mice impaired function. ZBP1 deficiency or mutation its domains reduced expression IFN-stimulated genes largely prevented early postnatal lethality hemizygous mutated (Adar1mZα/- mice). Adar1mZα/- showed upregulation editing endogenous retroelement-derived complementary reads, which represent likely source Z-RNAs activating ZBP1. Notably, promoted manner independent RIPK1, RIPK3, MLKL-mediated necroptosis caspase-8-dependent apoptosis, suggesting novel mechanism action. Thus, Z-RNA-dependent pathogenic responses by ZBP1, could contribute interferonopathies caused mutations.

Язык: Английский

Процитировано

146

Regulation and functions of non-m6A mRNA modifications DOI

Hanxiao Sun,

Kai Li,

Cong Liu

и другие.

Nature Reviews Molecular Cell Biology, Год журнала: 2023, Номер 24(10), С. 714 - 731

Опубликована: Июнь 27, 2023

Язык: Английский

Процитировано

145

DAMPs and DAMP-sensing receptors in inflammation and diseases DOI Open Access
Ming Ma, Wei Jiang, Rongbin Zhou

и другие.

Immunity, Год журнала: 2024, Номер 57(4), С. 752 - 771

Опубликована: Апрель 1, 2024

Язык: Английский

Процитировано

90

Exploiting RIG-I-like receptor pathway for cancer immunotherapy DOI Creative Commons
Yangfu Jiang, Hongying Zhang, Jiao Wang

и другие.

Journal of Hematology & Oncology, Год журнала: 2023, Номер 16(1)

Опубликована: Фев. 8, 2023

RIG-I-like receptors (RLRs) are intracellular pattern recognition that detect viral or bacterial infection and induce host innate immune responses. The RLRs family comprises retinoic acid-inducible gene 1 (RIG-I), melanoma differentiation-associated 5 (MDA5) laboratory of genetics physiology 2 (LGP2) have distinctive features. These not only recognize RNA intermediates from viruses bacteria, but also interact with endogenous such as the mislocalized mitochondrial RNA, aberrantly reactivated repetitive transposable elements in human genome. Evasion RLRs-mediated response may lead to sustained infection, defective immunity carcinogenesis. Therapeutic targeting provoke anti-infection effects, anticancer sensitize "immune-cold" tumors checkpoint blockade. In this review, we summarize current knowledge signaling discuss rationale for therapeutic cancer. We describe how can be activated by synthetic oncolytic viruses, mimicry radio-chemotherapy, agonists systemically delivered vivo. integration agonism interference CAR-T cells provides new dimensions complement cancer immunotherapy. Moreover, update progress recent clinical trials therapy involving activation modulation. Further studies mechanisms underlying will shed light on development therapeutics. Manipulation represents an opportunity clinically relevant therapy. Addressing challenges field help develop future generations

Язык: Английский

Процитировано

77

Noncanonical DNA structures are drivers of genome evolution DOI Creative Commons
Kateryna D. Makova, Matthias H. Weissensteiner

Trends in Genetics, Год журнала: 2023, Номер 39(2), С. 109 - 124

Опубликована: Янв. 3, 2023

In addition to the canonical right-handed double helix, other DNA structures, termed 'non-B DNA', can form in genomes across tree of life. Non-B regulates multiple cellular processes, including replication and transcription, yet its presence is associated with elevated mutagenicity genome instability. These discordant roles fuel enormous potential non-B drive genomic phenotypic evolution. Here we discuss recent studies establishing structures as novel functional elements subject natural selection, affecting evolution transposable (TEs), specifying centromeres. By highlighting contributions repeated adaptation changing environments, conclude that evolutionary analyses should include a perspective not only sequence, but also structure.

Язык: Английский

Процитировано

60

ADAR1 and ZBP1 in innate immunity, cell death, and disease DOI Creative Commons
Rajendra Karki, Thirumala‐Devi Kanneganti

Trends in Immunology, Год журнала: 2023, Номер 44(3), С. 201 - 216

Опубликована: Янв. 27, 2023

Язык: Английский

Процитировано

58

ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation DOI Creative Commons

Shi-Bin Hu,

Jacki Heraud-Farlow, Tao Sun

и другие.

Molecular Cell, Год журнала: 2023, Номер 83(21), С. 3869 - 3884.e7

Опубликована: Окт. 4, 2023

Язык: Английский

Процитировано

56

DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways DOI
Yi Huang, Wei Jiang, Rongbin Zhou

и другие.

Nature reviews. Immunology, Год журнала: 2024, Номер 24(10), С. 703 - 719

Опубликована: Апрель 29, 2024

Язык: Английский

Процитировано

33